Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
21 |
Material Type: Article
|
Freeze-dried tablets for oral vaccine delivery: Ease of administration and potential for production in existing facilitiesVaccine, 2020-05, Vol.38 (26), p.4142-4145 [Peer Reviewed Journal]2020 The Author ;2020. The Author ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2020.04.018 ;PMID: 32321686Full text available |
|
22 |
Material Type: Article
|
Ahd Hamidi: improving access to vaccine production capacityBulletin of the World Health Organization, 2019-12, Vol.97 (12), p.797-798 [Peer Reviewed Journal](c) 2019 The authors; licensee World Health Organization. ;Copyright World Health Organization Dec 2019 ;(c) 2019 The authors; licensee World Health Organization. 2019 ;ISSN: 0042-9686 ;EISSN: 1564-0604 ;DOI: 10.2471/BLT.19.031219 ;PMID: 31819287Full text available |
|
23 |
Material Type: Article
|
Bioprocess scale‐up/down as integrative enabling technology: from fluid mechanics to systems biology and beyondMicrobial biotechnology, 2017-09, Vol.10 (5), p.1267-1274 [Peer Reviewed Journal]2017 The Authors. published by John Wiley & Sons Ltd and Society for Applied Microbiology. ;2017 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology. ;2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1751-7915 ;ISSN: 1751-7907 ;EISSN: 1751-7915 ;DOI: 10.1111/1751-7915.12803 ;PMID: 28805306Full text available |
|
24 |
Material Type: Article
|
Recent Experience In Health Promotion At Johnson & Johnson: Lower Health Spending, Strong Return On InvestmentHealth Affairs, 2011-03, Vol.30 (3), p.490-499 [Peer Reviewed Journal]Copyright The People to People Health Foundation, Inc., Project HOPE Mar 2011 ;ISSN: 0278-2715 ;EISSN: 1544-5208 ;EISSN: 2694-233X ;DOI: 10.1377/hlthaff.2010.0806Full text available |
|
25 |
Material Type: Article
|
Delivering on the Promise of BiosimilarsBioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2019-12, Vol.33 (6), p.599-602 [Peer Reviewed Journal]Springer Nature Switzerland AG 2019 ;Copyright Springer Nature B.V. Dec 2019 ;ISSN: 1173-8804 ;EISSN: 1179-190X ;DOI: 10.1007/s40259-019-00388-9 ;PMID: 31606870Full text available |
|
26 |
Material Type: Article
|
Chemically programmed antibodiesTrends in biotechnology (Regular ed.), 2014-04, Vol.32 (4), p.186-197 [Peer Reviewed Journal]Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 2014 ;2014 Elsevier Ltd. All rights reserved. 2014 ;ISSN: 0167-7799 ;EISSN: 1879-3096 ;DOI: 10.1016/j.tibtech.2014.02.003 ;PMID: 24630478 ;CODEN: TRBIDMFull text available |
|
27 |
Material Type: Article
|
Current Status of Biosimilars in OncologyDrugs (New York, N.Y.), 2017-06, Vol.77 (9), p.985-997 [Peer Reviewed Journal]Springer International Publishing Switzerland 2017 ;Copyright Springer Science & Business Media Jun 2017 ;ISSN: 0012-6667 ;EISSN: 1179-1950 ;DOI: 10.1007/s40265-017-0743-z ;PMID: 28477160Full text available |
|
28 |
Material Type: Article
|
The world needs to prepare now to prevent polio resurgence post eradicationBMJ global health, 2022-12, Vol.7 (12), p.e011485 [Peer Reviewed Journal]2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 ;ISSN: 2059-7908 ;EISSN: 2059-7908 ;DOI: 10.1136/bmjgh-2022-011485 ;PMID: 36581335Full text available |
|
29 |
Material Type: Article
|
An Industry‐Driven Roadmap for Manufacturing in Regenerative MedicineStem cells translational medicine, 2018-08, Vol.7 (8), p.564-568 [Peer Reviewed Journal]2018 The Authors published by Wiley Periodicals, Inc. on behalf of AlphaMed Press ;2018 The Authors Stem Cells Translational Medicine published by Wiley Periodicals, Inc. on behalf of AlphaMed Press. ;2018. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 The Authors S C T M published by Wiley Periodicals, Inc. on behalf of AlphaMed Press ;ISSN: 2157-6564 ;EISSN: 2157-6580 ;DOI: 10.1002/sctm.18-0060 ;PMID: 30009571Full text available |
|
30 |
Material Type: Article
|
Exploring new packaging and delivery options for the immunization supply chainVaccine, 2017-04, Vol.35 (17), p.2265-2271 [Peer Reviewed Journal]The Authors ;2017 The Authors ;Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved. ;Copyright Elsevier Limited Apr 19, 2017 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2016.11.095 ;PMID: 28364941Full text available |
|
31 |
Material Type: Article
|
Assessing the Financial Benefits of Faster Development Times: The Case of Single-source Versus Multi-vendor Outsourced Biopharmaceutical ManufacturingClinical therapeutics, 2018-06, Vol.40 (6), p.963-972 [Peer Reviewed Journal]2018 Elsevier HS Journals, Inc. ;Copyright © 2018 Elsevier HS Journals, Inc. All rights reserved. ;Copyright Elsevier Limited Jun 2018 ;ISSN: 0149-2918 ;EISSN: 1879-114X ;DOI: 10.1016/j.clinthera.2018.04.011 ;PMID: 29755005Full text available |
|
32 |
Material Type: Article
|
Multidimensional Collaborative Management of Environment and Economy in the Internet-of-Things EnvironmentComputational intelligence and neuroscience, 2022, Vol.2022, p.5491677-11 [Peer Reviewed Journal]Copyright © 2022 Rui Yu and Ling Han. ;Copyright © 2022 Rui Yu and Ling Han. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0 ;Copyright © 2022 Rui Yu and Ling Han. 2022 ;ISSN: 1687-5265 ;EISSN: 1687-5273 ;DOI: 10.1155/2022/5491677 ;PMID: 35685159Full text available |
|
33 |
Material Type: Article
|
Enhancing enterovirus A71 vaccine production yield by microcarrier profusion bioreactor cultureVaccine, 2018-05, Vol.36 (22), p.3134-3139 [Peer Reviewed Journal]Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited May 24, 2018 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2017.02.042 ;PMID: 28274636Full text available |
|
34 |
Material Type: Article
|
Prescribing generics: All in a nameIndian journal of medical research (New Delhi, India : 1994), 2018-05, Vol.147 (5), p.442-444 [Peer Reviewed Journal]COPYRIGHT 2018 Medknow Publications and Media Pvt. Ltd. ;2018. This work is published under https://creativecommons.org/licenses/by-nc-sa/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright: © 2018 Indian Journal of Medical Research 2018 ;ISSN: 0971-5916 ;DOI: 10.4103/ijmr.IJMR_1940_17 ;PMID: 30082567Full text available |
|
35 |
Material Type: Article
|
Biosimilars: Impact of Biologic Product Life Cycle and European Experience on the Regulatory Trajectory in the United StatesClinical therapeutics, 2012-02, Vol.34 (2), p.400-419 [Peer Reviewed Journal]Elsevier HS Journals, Inc. ;2012 Elsevier HS Journals, Inc. ;Copyright © 2012 Elsevier HS Journals, Inc. All rights reserved. ;ISSN: 0149-2918 ;EISSN: 1879-114X ;DOI: 10.1016/j.clinthera.2011.12.005 ;PMID: 22244050Full text available |
|
36 |
Material Type: Article
|
Open-Label Study of the Stability of Sublingual Nitroglycerin Tablets in Simulated Real-Life ConditionsThe American journal of cardiology, 2018-12, Vol.122 (12), p.2151-2156 [Peer Reviewed Journal]2018 ;Copyright © 2018. Published by Elsevier Inc. ;Copyright Elsevier Limited Dec 15, 2018 ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2018.08.048 ;PMID: 30314813Full text available |
|
37 |
Material Type: Article
|
Environmental Management Breadth, Environmental Management Depth, and Manufacturing PerformanceInternational journal of environmental research and public health, 2019-11, Vol.16 (23), p.4628 [Peer Reviewed Journal]2019. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 by the authors. 2019 ;ISSN: 1660-4601 ;ISSN: 1661-7827 ;EISSN: 1660-4601 ;DOI: 10.3390/ijerph16234628 ;PMID: 31766404Full text available |
|
38 |
Material Type: Article
|
Sustainable Financing of Innovative Therapies: A Review of ApproachesPharmacoEconomics, 2016-10, Vol.34 (10), p.971-980 [Peer Reviewed Journal]Springer International Publishing Switzerland 2016 ;COPYRIGHT 2016 Springer ;Copyright Springer Science & Business Media Oct 2016 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-016-0416-x ;PMID: 27251182Full text available |
|
39 |
Material Type: Article
|
Physicians' Trust in the FDA's Use of Product-Specific Pathways for Generic Drug ApprovalPloS one, 2016-10, Vol.11 (10), p.e0163339-e0163339 [Peer Reviewed Journal]COPYRIGHT 2016 Public Library of Science ;COPYRIGHT 2016 Public Library of Science ;2016 Kesselheim et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Kesselheim et al 2016 Kesselheim et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0163339 ;PMID: 27768700Full text available |
|
40 |
Material Type: Article
|
Biosimilars and the long gameTrends in biotechnology (Regular ed.), 2015-05, Vol.33 (5), p.250-252 [Peer Reviewed Journal]Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited May 2015 ;ISSN: 0167-7799 ;EISSN: 1879-3096 ;DOI: 10.1016/j.tibtech.2015.01.001 ;PMID: 25907144Full text available |